IDEXX LABORATORIES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 521.1 USD | +3.60% |
|
+7.74% | -6.11% |
| 14/05 | Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620 | MT |
| 02/05 | BNP Paribas Adjusts Price Target on IDEXX Laboratories to $641 From $653 | MT |
Presentation Operator MessageOperator (Operator)Good morning and welcome to the IDEXX Laborato...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows:
- veterinary diagnoses for pets (91.6%);
- water quality analysis (4.6%);
- veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products;
- other (0.5%).
Net sales by source of income break down between product sales (57.1%) and services (42.9%).
Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Calendar
06/08/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
521.1
USD
Average target price
563.8
USD
Spread / Average Target
+8.19%
EPS Revisions
- Stock Market
- Equities
- IDXX Stock
- News IDEXX Laboratories, Inc.
- Transcript : IDEXX Laboratories, Inc., Q3 2020 Earnings Call, Oct 29, 2020